Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment89

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment23

Views

Views
September 20255
October 20253
November 20257
December 20254
January 20261
February 20260
March 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom7
United States6
Brazil6
Algeria1
Mexico1
Peru1
Paraguay1
 

Top cities views

Views
Ashburn3
Annaba1
Caraguatatuba1
Coyoacán1
Dallas1
Lima1
London1
Olímpia1
Pelotas1
Pirassununga1